Treatment Registry
TR-0450 ActiveRecorded September 2026Last verified October 2026

Brand semaglutide

Sold by Heally · Oral tablet · every brand semaglutide record

Price

TermPublished rateCharged today
Wegovy pill 1.5 mg starter dose; advertised priceIntroductory

Advertised starting amount; prescribed dose, quantity and initial invoice are not established.

“Starting at $149 / month For the 1.5 mg dose”

$149Published figureCharged todayNot verified
Rybelsus advertised starting price

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Advertised starting amount; prescribed dose, quantity and initial invoice are not established.

“Rybelsus from $199/month.”

$199Published figureCharged todayNot verified
Price sources
Visit Heally

We earn nothing from this link. It opens Heally's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberLive visit
CancellationCurrent product pages say there is no required subscription and payment is due only when a refill is ordered; the general FAQ still describes automatically scheduled refills until cancellation. Confirm which arrangement applies. The FAQ also describes a card authorization about 48 hours before an appointment and charge only after approval. A universal cancellation deadline, refund rule or charge amount is not established. https://getheally.com/patients/faq
MembershipNone. “No monthly memberships or contracts required.”
Consult fee$0. The advertised program includes a free physician consultation; other visit types and final prescription charges may differ.

Recorded from getheally.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Rybelsus (oral brand semaglutide) is also sold but the page explicitly states it 'is not FDA approved for weight loss,' so it is excluded from these entries. The $149/month oral figure is described as the 'semaglutide pill' price; it is unclear from the text whether this is the brand Wegovy pill (approved Dec 2025, also discussed on the page) or a general oral program, so it is recorded generically as oral semaglutide.
  2. 2. October 2026 — Current product pages advertise free physician consultation and no required monthly membership. The general FAQ says consultation pricing varies by visit; the free offer is scoped to these advertised programs, not every service. https://getheally.com/patients/faq
  3. 3. October 2026 — The website describes a nationwide clinician network and patients across all 50 states. It does not establish that each medication, pharmacy or dose is available in every state. No assigned dispensing pharmacy is named on the reviewed program pages. https://getheally.com/patients/about-us
  4. 4. October 2026 — Current product pages say there is no required subscription and payment is due only when a refill is ordered; the general FAQ still describes automatically scheduled refills until cancellation. Confirm which arrangement applies. The FAQ also describes a card authorization about 48 hours before an appointment and charge only after approval. A universal cancellation deadline, refund rule or charge amount is not established. https://getheally.com/patients/faq
  5. 5. October 2026 — The current offer explicitly names the Wegovy pill and its 1.5 mg starter dose. The prior unqualified oral classification is refined to brand semaglutide, not evidence of a sold-formulation change. Rybelsus is separately offered for diabetes from $199/month; its lack of a weight-loss indication is not a reason to erase it from this treatment catalog. https://getheally.com/patients/wegovy-pills https://getheally.com/patients/rybelsus

4 further notes concern other Heally programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0450
Medication category
brand semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). Heally — brand semaglutide (TR-0450). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0450

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.